These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38334205)

  • 1. Patient and physician decision-making dynamics in overactive bladder care: A mixed methods study.
    Sitto HM; Brodsky CN; Wittmann D; Wallner LP; Streur C; DeJonckheere M; Stoffel JS; Cameron AP; Sarma A; Quentin Clemens J; Ippolito GM
    Neurourol Urodyn; 2024 Mar; 43(3):565-573. PubMed ID: 38334205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient Perceptions Impact Progression to Third-Line Therapy for Treatment of Overactive Bladder.
    Iyer S; Amegashie C; deMartelly V; Letko J; Glass D; Fetzer L; Botros S; Wroblewski K; Valaitis S
    J Urol; 2021 Nov; 206(5):1240-1247. PubMed ID: 34184922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivering patient-centered care through shared decision making in overactive bladder.
    Paudel R; Lane GI
    Neurourol Urodyn; 2022 Apr; 41(4):884-893. PubMed ID: 35332575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient and physician preferences for oral pharmacotherapy for overactive bladder: two discrete choice experiments.
    Heisen M; Baeten SA; Verheggen BG; Stoelzel M; Hakimi Z; Ridder A; van Maanen R; Stolk EA
    Curr Med Res Opin; 2016; 32(4):787-96. PubMed ID: 26789823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Patient-Centered Approach to Refractory Overactive Bladder and Barriers to Third-Line Therapy.
    Davenport A; Stark S; Quian A; Sheyn D; Mangel J
    Obstet Gynecol; 2019 Jul; 134(1):141-148. PubMed ID: 31188332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient preference elicitation instrument, OABCare, to facilitate shared decision-making in the care of overactive bladder.
    Chhatre S; Newman DK; Wein AJ; Jayadevappa R
    Neurourol Urodyn; 2021 Mar; 40(3):791-801. PubMed ID: 33565118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating and understanding combination therapy decision drivers for the treatment of overactive bladder in the United States.
    Kraus SR; Li J; Kristy RM; Lockefeer A; Yang H; Zhou M; Walker DR
    J Int Med Res; 2022 May; 50(5):3000605221098176. PubMed ID: 35588263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relative importance of health related quality of life and prescription insurance coverage in the decision to pharmacologically manage symptoms of overactive bladder.
    Harpe SE; Szeinbach SL; Caswell RJ; Corey R; McAuley JW
    J Urol; 2007 Dec; 178(6):2532-6; discussion 2536. PubMed ID: 17937937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Seeing a doctor is just like having a date": a qualitative study on doctor shopping among overactive bladder patients in Hong Kong.
    Siu JY
    BMC Fam Pract; 2014 Feb; 15():27. PubMed ID: 24502367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatments for overactive bladder: focus on pharmacotherapy.
    Geoffrion R;
    J Obstet Gynaecol Can; 2012 Nov; 34(11):1092-1101. PubMed ID: 23231848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient and physician views of shared decision making in cancer.
    Tamirisa NP; Goodwin JS; Kandalam A; Linder SK; Weller S; Turrubiate S; Silva C; Riall TS
    Health Expect; 2017 Dec; 20(6):1248-1253. PubMed ID: 28464430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why do some patients prefer to leave decisions up to the doctor: lack of self-efficacy or a matter of trust?
    Chawla N; Arora NK
    J Cancer Surviv; 2013 Dec; 7(4):592-601. PubMed ID: 23892559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The patient perspective on overactive bladder: a mixed-methods needs assessment.
    Filipetto FA; Fulda KG; Holthusen AE; McKeithen TM; McFadden P
    BMC Fam Pract; 2014 May; 15():96. PubMed ID: 24885491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survey of patients and physicians on shared decision-making in treatment selection in relapsed/refractory multiple myeloma.
    Bylund CL; Eggly S; LeBlanc TW; Kurtin S; Gandee M; Medhekar R; Fu A; Khurana M; Delaney K; Divita A; McNamara M; Baile WF
    Transl Behav Med; 2023 Apr; 13(4):255-267. PubMed ID: 36688466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Choosing the Most Efficacious and Safe Oral Treatment for Idiopathic Overactive Bladder: A Systematic Review and Network Meta-analysis.
    Mostafaei H; Salehi-Pourmehr H; Jilch S; Carlin GL; Mori K; Quhal F; Pradere B; Grossmann NC; Laukhtina E; Schuettfort VM; Aydh A; Sari Motlagh R; König F; Roehrborn CG; Katayama S; Rajwa P; Hajebrahimi S; Shariat SF
    Eur Urol Focus; 2022 Jul; 8(4):1072-1089. PubMed ID: 34563481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy decision-making among patients with breast cancer in Japan: results of an online survey.
    Shimizu C; Sakata Y; Sakai R; Ikezawa H; Uetaki Y; Matsuoka T
    Breast Cancer; 2019 Nov; 26(6):799-807. PubMed ID: 31177375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient preferences for treating refractory overactive bladder in the UK.
    Hashim H; Beusterien K; Bridges JF; Amos K; Cardozo L
    Int Urol Nephrol; 2015 Oct; 47(10):1619-27. PubMed ID: 26347077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Mobile Application Patient Decision Aid for Treatment of Overactive Bladder.
    Khanijow KD; Leri D; Arya LA; Andy UU
    Female Pelvic Med Reconstr Surg; 2021 Jun; 27(6):365-370. PubMed ID: 32969841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A qualitative systematic review of internal and external influences on shared decision-making in all health care settings.
    Truglio-Londrigan M; Slyer JT; Singleton JK; Worral P
    JBI Libr Syst Rev; 2012; 10(58):4633-4646. PubMed ID: 27820528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are Electronic and Paper Questionnaires Equivalent to Assess Patients with Overactive Bladder?
    Palmer C; Farhan B; Nguyen N; Zhang L; Do R; Nguyen DV; Ghoniem G
    J Urol; 2018 Aug; 200(2):369-374. PubMed ID: 29605443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.